Beijing Science Sun Pharmaceutical (300485.SZ) subsidiary withdraws a drug registration application.

Beijing Science Sun Pharmaceutical (300485.SZ) announced that its subsidiary, Beijing Science Biological Pharmaceutical Co., Ltd. (referred to as "Science Biological"), recently received a "Medicine Registration Application Termination Notice" issued by the National Medical Products Administration, agreeing to withdraw its application for the registration of Dapagliflozin tablets. The announcement stated that Science Biological submitted an application for the market approval of Dapagliflozin tablets to the National Medical Products Administration in March 2025 and was accepted. Due to changes in policies and regulations and other factors, further improvement of application materials is needed. Therefore, they have voluntarily withdrawn this application.